Clinical Trial Update: INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of INM-755 (cannabinol) cream for epidermolysis bullosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa
• Epidermolysis Bullosa Dystrophica
• Epidermolysis Bullosa Simplex
• Junctional Epidermolysis Bullosa
• Kindler Syndrome

Drugs mentioned

• INM-755 (cannabinol) cream (cannabinol)

Snippet

Sponsor: InMed Pharmaceuticals Inc. | Conditions: Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional | Phase 2 | Status: COMPLETED